The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A

por Dedieu, S, Canron, X, Rezvani, HR, Bouchecareilh, M, Mazurier, F, Sinisi, R, Zanda, M, Moenner, M, Bikfalvi, A, North, S
Publicado 2010